OR WAIT null SECS
Growth and Advancements in Fill/Finish
Employing novel technologies and more patient-centric approaches
Delving into Biopharmaceutical Development and Manufacturing
Quality Considerations in Changing Excipient Providers
December 05, 2022
In addition, personnel, equipment, and facilities from the acquired companies will expand Reaction Biology’s presence in Germany while enabling its global customers to leverage Bioassay’s expansive portfolio of regulated clinical and commercial services.
December 03, 2022
Overall industry growth conceals growing numbers of smaller, faster-paced, adaptable corporate structures.
Unique solutions are required to protect inherently unstable messenger RNA.
Although well known in R&D, PK/PD studies are an equally powerful tool for promoting successful biologic drug development.
Unique dosage forms, personalized medicine, and flexible manufacturing are possible with 3DP.
QMM is an evolutionary advancement in FDA’s quality management maturity initiative that provides industry with a viable methodology to assess and improve manufacturing quality and supply chain reliability.
December 02, 2022
Pharmaceutical Technology Europe got the scoop on Agilent's new Dissolution Testing Centre of Excellence in Craven Arms, UK.
Dissolution testing is experiencing a refresh thanks to a variety of market drivers.
The European Human Medicines Directive and Regulation is due to be updated by the end of 2022, but what changes are on the cards?
Anti-obesity drugs have the potential to be the next blockbusters, according to market analysis.